A Study to Investigate the Effect of Inhaling Single Doses of Different Formulations of GW642444M in Asthmatic Patients
Status:
Completed
Trial end date:
2008-10-04
Target enrollment:
Participant gender:
Summary
This study will involve the use of a new medicine called GW642444 being developed for the
treatment of asthma and chronic obstructive pulmonary disease (COPD). The purpose of the
study is to see how safe and how well tolerated the study drug is when inhaled in two
different formulations as a fine powder by asthmatic patients. In addition, the study is
designed to examine the effect of the study drug on the lungs, how the study drug affects
parts of the body other than the lungs and to see how the body affects the study drug when it
is given in single doses.